BAROS
LOE Approachingsodium bicarbonate; tartaric acid
NDAORALGRANULE, EFFERVESCENT
Approved
Aug 1985
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
12
Data completeness
2/8 — Basic
Drug data last refreshed 5d ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
BAROS is an oral effervescent granule combination of sodium bicarbonate and tartaric acid, approved in 1985 for systemic alkalinization and relief of acid indigestion. The formulation works by neutralizing gastric acid through the bicarbonate component while tartaric acid modulates the pH effect. This is an older, well-established symptomatic therapy for minor gastrointestinal acid-related conditions.
LOE Approaching
Product is in late-stage lifecycle with moderate competitive pressure (30%), indicating a shrinking team focus and transition planning toward LOE management.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (12)
Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure
Started Apr 2026
2,500 enrolled
Heart FailureHeart Failure NYHA Class IIHeart Failure NYHA Class III
Impact of Barostimulation on Hemodynamics in Adults With Heart Failure
Started Jan 2026
58 enrolled
HFrEF - Heart Failure With Reduced Ejection Fraction
Symptomatic CRT Patients: Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence
Started Jul 2023
5 enrolled
Heart Failure
Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence (REBALANCE Registry)
Started Jun 2020
5,000 enrolled
Heart Failure
BAROSTIM THERAPY™ In Heart Failure With Preserved Ejection Fraction
Started Mar 2017
70 enrolled
Heart Failure
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.